Please Provide Current Release of Information!
Please provide current Release of Information (ROI) for those whom you authorize to discuss your care. ROIs expire after one year. Thank you!
Important information on Vyvanse and other ADHD medication issues!
Dear Patients
As of late August 2023, Vyvanse now has a generic option on the market—called lisdexamfetamine. We have recently learned that many insurance companies immediately removed the brand name Vyvanse from their formularies, even before pharmacies have the generic version in stock. This was a premature move, which will inevitably cause many issues for patients and doctors.
This change comes amidst a national shortage of all ADHD medications. In the last several months we have needed to substitute the majority of our patients on different medications. This has created an exponential increase in the number of pre-authorizations we are managing.
We are sharing this to make you aware, and to let you know that we are working hard to determine how we can best help our patients on Vyvanse specifically, and ADHD medication in general. We appreciate your patience with our staff as we navigate these issues alongside you.
This article offers some additional information about the Vyvanse issue.
https://publicgoodnews.com/2023/06/26/generic-vyvanse-adhd-medication/
Thank you, RCBM Staff
Please make sure your insurance information is up to date with our office
Please make sure to provide our staff with current insurance information (email to billing@rcbm.net)
